In a first, Glenmark launches Lobeglitazone in India for uncontrolled type-II diabetes in adults
With this launch, the company aims to improve glycemic levels in uncontrolled diabetics and create a new pathway to treat insulin…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.